Fludrocortisone, Oral
dc.contributor.advisor | Mitsnefes, Mark |
dc.contributor.author | Dickinson, Kimberly |
dc.contributor.other | Children's Hospital of Philadelphia |
dc.date.accessioned | 2024-06-10T19:03:22Z |
dc.date.available | 2024-06-10T19:03:22Z |
dc.date.created | 2022-02-01 |
dc.description | This medication concept set includes oral fludrocortisone. No combinations are included. This code list was generated by taking all descendants from the SCDG drug level for oral fludrocortisone. The codeset was reviewed by the PRESERVE BPZ workgroup led by Mark Mitsnefes. This codeset was created as part of the inclusion/exclusion criteria for the cohort of patients for the development and evaluation of EHR-based pediatric blood pressure Z-scores. One of the exclusion criteria was any exposure to an oral form of the corticosteroid fludrocortisone. This medication concept set contains only RxNorm and RxNorm Extension vocabularies. |
dc.description.abstract | Concept set to identify patients with the an exposure to the corticosteroid fludrocortisone. |
dc.identifier.uri | https://pedsnet.org/metadata/handle/20.500.14642/528 |
dc.provenance | Preserving Kidney Function in Children with Chronic Kidney Disease (PRESERVE) |
dc.publisher | PEDSnet |
dc.relation.isreferencedby | Mitsnefes MM, Maltenfort M, Denburg MR, Flynn JT, Schuchard J, et al. November 2023. "Derivation of paediatric blood pressure percentiles from electronic health records." _EBioMedicine_. 98:104885. <br>DOI: [10.1016/j.ebiom.2023.104885](https://doi.org/10.1016/j.ebiom.2023.104885) |
dc.relation.uri | https://github.com/PRESERVE-Coordinating-Center/PRESERVE_Variables/blob/dfe52bdc48cfcfd6b358d4a424b5d39749554025/codesets/drug/rx_fludrocortisone.csv |
dc.rights | a CC-BY Attribution 4.0 License. |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ |
dc.subject | Concept Set Development::Content Data Model::PEDSnet Data Model |
dc.subject | Concept Set Development::Content Data Model::PCORnet Data Model |
dc.subject | Concept Set Development::Concept Set Development Strategy::Variable Characterization::Independent Variable |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Brand Pack Name |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug Form |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug Form |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Branded Drug Component |
dc.subject | Concept Set Development::Concept Set Development Strategy::Medication Characterization::Semantic Clinical Drug Component |
dc.subject.mesh | Corticosteroid |
dc.subject.mesh | Receptor Agonist |
dc.subject.mesh | Hormone |
dc.subject.mesh | Steroid |
dc.subject.other | RxNorm |
dc.subject.other | RxNorm Extension |
dc.title | Fludrocortisone, Oral |
dspace.entity.type | ConceptSet |
local.quality.status | Research-Ready |
local.subject.flat | PEDSnet Data Model |
local.subject.flat | PCORnet Data Model |
local.subject.flat | Independent Variable |
local.subject.flat | Brand Pack Name |
local.subject.flat | Semantic Branded Drug |
local.subject.flat | Semantic Clinical Drug |
local.subject.flat | Semantic Branded Drug Form |
local.subject.flat | Semantic Clinical Drug Form |
local.subject.flat | Semantic Branded Drug Component |
local.subject.flat | Semantic Clinical Drug Component |
relation.isStudyOfConceptSet | 6df51ca1-7a01-4551-b1f1-ca70aaf2c5ae |
relation.isStudyOfConceptSet | 61bcd30c-d82d-4880-bdc8-ad22016b9e54 |
relation.isStudyOfConceptSet.latestForDiscovery | 6df51ca1-7a01-4551-b1f1-ca70aaf2c5ae |
Files
Original bundle
1 - 1 of 1